Shine Spect USA Updates Clinical and Safety Guidelines for Xenon Xe-133 Gas

Shine Spect USA, LLC updated the product information for Xenon Xe-133 gas on September 11, 2026. The updated documentation provides clinical and technical specifications for the radioactive diagnostic agent, which medical professionals use primarily for pulmonary ventilation studies and blood flow measurements.

The updated filing outlines the chemical properties, clinical pharmacology, and administration guidelines for the gas. It details the necessary safety protocols for handling the radioactive material, including dosage recommendations and contraindications for patient use. The document also specifies the physical characteristics of the isotope and the required storage conditions to maintain the stability of the product. These guidelines serve as the official reference for healthcare providers regarding the clinical application and safety requirements of Xenon Xe-133.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: September 11, 2026

Author

GOAI